CURE vs. UGL
CURE (Direxion Daily Healthcare Bull 3x Shares) and UGL (ProShares Ultra Gold) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while UGL is a Leveraged Commodities fund tracking the Bloomberg Gold Subindex (200%). Both are passively managed. Over the past 10 years, CURE returned 13.49%/yr vs 16.37%/yr for UGL. At a 0.03 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.95%/yr for UGL.
Performance
CURE vs. UGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -7.96% return, which is significantly higher than UGL's -12.66% return. Over the past 10 years, CURE has underperformed UGL with an annualized return of 13.49%, while UGL has yielded a comparatively higher 16.37% annualized return.
CURE
- 1D
- -0.55%
- 1M
- 13.53%
- YTD
- -7.96%
- 6M
- -6.00%
- 1Y
- 26.46%
- 3Y*
- 3.05%
- 5Y*
- 1.51%
- 10Y*
- 13.49%
UGL
- 1D
- 0.08%
- 1M
- -20.27%
- YTD
- -12.66%
- 6M
- -12.99%
- 1Y
- 32.76%
- 3Y*
- 47.90%
- 5Y*
- 24.60%
- 10Y*
- 16.37%
CURE vs. UGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -7.96% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
UGL ProShares Ultra Gold | -12.66% | 137.57% | 46.36% | 15.56% | -7.59% | -12.30% | 39.04% | 31.11% | -8.02% | 22.50% |
Correlation
The correlation between CURE and UGL is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.06 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | 0.03 |
The correlation between CURE and UGL shifts across timeframes, from 0.03 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. UGL — Risk / Return Rank
CURE
UGL
CURE vs. UGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Gold (UGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | UGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.01 | ||
| Sortino ratioReturn per unit of downside risk | +0.11 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.16 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 0.85 | 0.71 | +0.15 |
| Martin ratioReturn relative to average drawdown | 1.94 | 1.85 | +0.09 |
Loading charts...
Drawdowns
CURE vs. UGL - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum UGL drawdown of -75.93%. Use the drawdown chart below to compare losses from any high point for CURE and UGL.
Loading charts...
Drawdown Indicators
| CURE | UGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -75.93% | +6.74% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -46.64% | +15.54% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -46.64% | -5.29% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -46.64% | -5.59% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -46.64% | -22.55% |
Current DrawdownCurrent decline from peak | -26.94% | -43.37% | +16.43% |
Average DrawdownAverage peak-to-trough decline | -18.16% | -43.62% | +25.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.71% | 17.76% | -4.05% |
Volatility
CURE vs. UGL - Volatility Comparison
The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 14.30%, while ProShares Ultra Gold (UGL) has a volatility of 15.51%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than UGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | UGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.30% | 15.51% | -1.21% |
Volatility (6M)Calculated over the trailing 6-month period | 30.87% | 48.64% | -17.77% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.32% | 54.39% | -10.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.84% | 36.61% | +7.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.59% | 32.58% | +17.01% |
CURE vs. UGL - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is higher than UGL's 0.95% expense ratio.
Dividends
CURE vs. UGL - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.16%, while UGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.16% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
UGL ProShares Ultra Gold | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE and UGL have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UGL has higher volatility (15.51%) compared to CURE (14.30%). In terms of maximum drawdown, CURE dropped -69.19% vs UGL's -75.93%.
On 10-year performance, UGL leads with 16.37% vs 13.49% for CURE. On fees, UGL is cheaper at 0.95% per year. On volatility, CURE has been the lower-risk option at 14.30%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UGL has performed better with a 16.37% return vs 13.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UGL is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.
CURE has the higher dividend yield at 1.16%, compared with 0.00% for UGL.
CURE is categorized as Leveraged Equities, while UGL is Leveraged Commodities. CURE tracks Health Care Select Sector Index (300%), while UGL tracks Bloomberg Gold Subindex (200%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.08% for CURE and 0.95% for UGL.
UGL currently has the higher Sharpe Ratio (0.61 vs 0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and UGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer